NMRA
NMRA
NASDAQ · Pharmaceuticals

Neumora Therapeutics Inc

Small-Cap Stocks Penny Stocks Pharmaceutical Stocks Healthcare Stocks
$1.63
-0.01 (-0.61%)
As of Aug 9, 10:26 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 12 80%
Hold 2 13%
Sell 1 7%
Price Target
Analyst Price Target +963.8% upside
Low Target $11.85
Average Target $17.34
High Target $21.76
Current Price $1.63
Current
$1.63
Target
$17.34
$11.85 $17.34 avg $21.76
Scenario Analysis
Bear Case
$11.85
627.0%
Low target
Base Case
$17.34
+963.8%
Avg target
Bull Case
$21.76
+1,235.0%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$3.65
-55.3% from high
52-Week Low
$0.83
+96.3% from low
Target vs 52W High
$17.34
+375.1% vs high
Next Earnings Report
Aug 12, 2026
1d
tomorrow
EPS Est: $-0.24
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
 Strong Sell 45 31% — +0.0%
JNJ
Johnson & Johnson
 Buy 31 71% $299.55 +15.5%
MRK
Merck & Co. Inc.
 Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
 Hold 36 39% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
 Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
 Hold 24 54% $209.87 +188.8%